A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants
Condition: Healthy Interventions: Drug: Selpercatinib; Drug: Moxifloxacin; Drug: Placebo Sponsors: Eli Lilly and Company; Loxo Oncology, Inc. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials